Delek US director sells 6,397 shares at $71.50

A Delek US Holdings director completed a Rule 10b5-1 trading plan with a 6,397-share sale and now holds 26,407 shares directly.

Rhea-AI Filing Summary

Delek US Holdings, Inc. reported that director Vicky Sutil sold 6,397 shares of common stock on September 4, 2026 at $71.50 per share in an open-market or private transaction. The sale was made under a Rule 10b5-1 trading plan, which this transaction completes, and Sutil now directly holds 26,407 shares of Delek US common stock.

Insider Trade Summary 10b5-1

Net Seller: 6,397 shares

Net Sell 1 txn

Insider Sutil Vicky

Role Director

Sold 6,397 shs ($457K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	6,397	$71.50	$457K

Holdings After Transaction: Common Stock — 26,407 shares (Direct)

Footnotes (1)

1. F1. This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). This transaction completes this plan.

Key Figures

Shares sold: 6,397 shares Sale price per share: $71.50 per share Shares owned after transaction: 26,407 shares

3 metrics

Shares sold 6,397 shares Common stock sale reported for September 4, 2026

Sale price per share $71.50 per share Price for the 6,397 shares of common stock sold on September 4, 2026

Shares owned after transaction 26,407 shares Direct holdings of Delek US common stock by Vicky Sutil following the sale

Key Terms

Rule 10b5-1 plan, affirmative defense conditions, Common Stock

3 terms

Rule 10b5-1 plan regulatory

"This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

affirmative defense conditions regulatory

"and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)"

Common Stock financial

"Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

What insider transaction did Delek US Holdings (DK) report for Vicky Sutil?

Delek US Holdings reported that director Vicky Sutil sold 6,397 shares of the company’s common stock on September 4, 2026 in a sale classified as an open-market or private transaction, and the filing lists this as a disposition of shares.

At what price were the DK shares sold in Vicky Sutil’s September 4, 2026 transaction?

The sale by director Vicky Sutil was reported at a price of $71.50 per share for the 6,397 shares of Delek US Holdings common stock sold on September 4, 2026, according to the transaction details.

How many Delek US Holdings (DK) shares does Vicky Sutil own after this sale?

After the reported sale, director Vicky Sutil directly owns 26,407 shares of Delek US Holdings common stock. The filing identifies this amount as the total direct holdings following the 6,397-share disposition.

Was Vicky Sutil’s DK share sale made under a Rule 10b5-1 trading plan?

Yes. A footnote states the sale was made pursuant to a Rule 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), and it further explains that this transaction completes this plan.

Does the Form 4 for Delek US Holdings (DK) show any derivative securities for Vicky Sutil?

No derivative securities are listed for director Vicky Sutil in this Form 4. The filing’s derivative section is empty, and only the common stock sale and resulting direct common share holdings are reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 08:28 PM Accepted by SEC EDGAR 09/09/2026 - 08:27 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sutil Vicky

(Last) (First) (Middle)

310 SEVEN SPRINGS WAY

SUITE 500

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/04/2026		S		6,397(1)	D	$71.5	26,407	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). This transaction completes this plan.

Remarks:

	/s/ Misty Lavender	09/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)